International Drug Agency for Pharmaceutical Industry (IDI) is an Egyptian joint-stock company which has been established in 2000 in accordance with investment law No. 8 issued in 1997. Chairman: Dr. Hussien Hassan. Managing director: Dr. Hasan Hassan. IDI is a Stat-of-the-art facility that accommodates the production of product types including tablets, capsules, and Dry powders. By: designing, producing, packaging, testing, storing, and distributing their products for local market & Exporting. IDI has an outstanding generic product pipeline. These products are developed under the direction of highly skilled scientists and chemists employed and in collaboration with other global pharmaceutical companies and research facilities. IDI product pipeline cover most of known pharmaceutical groups: Anti-diabetic, Anti platelet, Anti-Viral, Anti-depressant, Multi vitamins. Anti-biotic (non B-lactam). Dietary supplement. IDI is approved by GSK as a manufacturing contractor. IDI facility approved for exporting to the following countries: (Libya – Morocco – Republic of Yemen).